GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Common Stock

StemRIM (TSE:4599) Common Stock : 円208 Mil (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Common Stock?

StemRIM's quarterly common stock increased from Jul. 2023 (円16 Mil) to Oct. 2023 (円52 Mil) and increased from Oct. 2023 (円52 Mil) to Jan. 2024 (円208 Mil).

StemRIM's annual common stock increased from Jul. 2021 (円32 Mil) to Jul. 2022 (円76 Mil) but then declined from Jul. 2022 (円76 Mil) to Jul. 2023 (円16 Mil).


StemRIM Common Stock Historical Data

The historical data trend for StemRIM's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Common Stock Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Common Stock
Get a 7-Day Free Trial 812.48 49.29 32.42 76.32 15.75

StemRIM Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.92 159.57 15.75 51.66 207.62

StemRIM Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines